
Jade Biosciences (JBIO) has had the highest return since April 1, 2024 by a small-cap US stock, returning 60,995.6%.
| ASSET | % RETURN |
|---|---|
Jade Biosciences (JBIO) | 60,995.62% |
Goldgroup Mining (GORO) | 8,025% |
Mega Fortune Company Limited Ordinary Shares (MGRT) | 3,158.15% |
Monopar Therapeutics (MNPR) | 1,930.18% |
Eton Pharmaceuticals (ETON) | 1,559.22% |
Stewards Inc Common Stock (SWRD) | 1,473.86% |
Power Solutions International, Inc Common Stock (PSIX) | 1,355.32% |
Vistance Networks (VISN) | 1,346.36% |
BUUU (BUUU) | 1,275% |
Nutex Health (NUTX) | 1,038.16% |
United States Antimony (UAMY) | 1,012.5% |
SharonAI Holdings, Inc Class A Common Stock (SHAZ) | 959.47% |
Personalis (PSNL) | 886.67% |
Santacruz Silver Mining Ltd Common Shares (SCZM) | 744.74% |
Fossil (FOSL) | 706.86% |
Sellas Life Sciences (SLS) | 625.24% |
Inhibrx Biosciences (INBX) | 613.37% |
Hycroft Mining (HYMC) | 583.04% |
Entravision Communications (EVC) | 581.09% |
Flotek Industries (FTK) | 570.86% |
Roma Green Finance Limited Ordinary Shares (ROMA) | 557.31% |
Frequency Electronics (FEIM) | 533.69% |
Avino Silver & Gold Mines (ASM) | 524.81% |
Corvus Pharmaceuticals (CRVS) | 495.51% |
GeneDx (WGS) | 460.66% |
Small-cap stocks are treated as having a market cap between $300M and $2B.